Detemination of The Main Advanced Glycation End Product of The Maillard Reaction and Its Significance as A Biochemical Marker for Diabetic Complications
Detemination of The Main Advanced Glycation End Product of The Maillard Reaction and Its Significance as A Biochemical Marker for Diabetic Complications
批准号:
07557076
负责人:
HORIUCHI Seikoh
金额:
$9.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
葡萄糖与蛋白质在体外孵育可形成希夫碱和Amadori产物等早期产物。在进一步孵育后,这些早期产物会导致形成高级糖基化终产物(AGE),其特征是荧光、棕色以及分子内和分子间的交联。最近使用抗AGE抗体的免疫学研究表明,AGE修饰在衰老和AGE增强型疾病过程中具有潜在的作用,如动脉粥样硬化和糖尿病并发症。为了解决这一问题,需要确定在体内表达的主要年龄结构(S)。在本研究中,我们从AGE-赖氨酸衍生物中分离出主要的AGE-结构,并对其化学结构进行了测定。通过两年的研究,获得了以下结果:[1]AGE-样品是在α-对甲苯磺酰-赖氨酸甲酯与葡萄糖长期孵育后得到的,并从该样品中提纯了主要的荧光化合物X1。通过质谱学、~1H-核磁共振和~(13)C-核磁共振的化学分析,成功地鉴定了其结构为:1,7-二取代-5-(1,2,3,4-四羟基丁基)-1,4-二氢-4-氧-1,7-萘基-阳离子,表明两个赖氨酸残基是由来自两个葡萄糖分子的吡啶结构交联的。[2]使用兔多克隆抗X1抗体的免疫学研究表明,X1存在于(I)人晶状体蛋白,(Ii)泡沫细胞以及人动脉粥样硬化病变的细胞外空间,(Iii)糖尿病肾病的肾小球和肾小管,(4)透析相关淀粉样变的腕管沉积(β2-微球蛋白);(5)光化性弹力增生症皮肤真皮的弹性蛋白纤维。这些结果表明,X1是体内主要的AGE结构之一,在糖尿病并发症和血管壁动脉粥样硬化等衰老和/或AGE增强型疾病过程中发挥着重要作用。
英文摘要
Incubation of glucose with proteins in vitro results in formation of early-products such as Schiff base and Amadori product. Upon further incubations, these early-products leads to formation of advanced glycation end products (AGE) which are characterized by fluorescence, brown color and intra-and intermolecular crosslinking. Recent immunological studies using anti-AGE antibody suggest a potential role of AGE-modification in aging and age-enhanced disease processes such as atherosclerosis and diabetic complications. To solve this suggestion, a main AGE-structure (s) expressed in vivo is to be determined. In the present study, we isolated the main AGE-structure from AGE-lysine derivative and determined its chemical structure.The following results were obtained by two-years projects.[1] The AGE-sample was obtained after long-term incubation of alpha-tosyl-lysine-methyl ester with glucose and the main fluorescent compound named as X1 was purified from this sample. Chemical analyzes by mass spectroscopy and 1H-NMR and 13C-NMR successfully identified its structure as 1,7-disubstituted-5- (1,2,3,4-tetrahydroxybutyl) -1,4-dihydro-4-oxo-1,7-naphthyridinium cation, indicating two lysine residues are crosslinked by pyridinium structure derived from two glucose molecules.[2] Immunological studies using the rabbit polyclonal anti-X1 antibody demonstrated the presence of X1 in (i) human lens proteins, (ii) foam cells as well as in extracellular spaces in human atherosclerotic lesions, (iii) glomerulus and renal tubules of diabetic nephropathy, (iv) in Carpal tunnel deposits (beta2-microglobulin) of dialysis-related amyloidosis, (v) elastin fibers of skin dermis in actinic elastosis. These results indicate that X1, one of the main AGE-structures in vivo, plays an important role in aging and/or age-enhanced disease processes such as diabetic complications and atherosclerosis of vascular walls.
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Meng, J.: "Advanced glycation end-products of the Maillard reaction in aortic pepsin-insoluble collagen from diabetic rats" Diabetes. 45. 1037-1043 (1996)
孟,J.:“糖尿病大鼠主动脉胃蛋白酶不溶性胶原蛋白中美拉德反应的高级糖基化终产物”糖尿病。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hammes, H-P.: "Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina" Lab.Invest. 75. 325-338 (1996)
Hammes, H-P.:“通过高级糖基化对玻连蛋白进行修饰可改变体外和糖尿病视网膜的功能特性”Lab.Invest。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kume,S.: "Immunohistrochemical and ultrastrucutral detection of advanced a glycation end products in altherosclerotic lesions of human aorta using a novel specific monoclonal antibody" Am.J.Pathol.147. 654-667 (1995)
Kume,S.:“使用新型特异性单克隆抗体对人主动脉动脉粥样硬化病变中的高级糖基化终产物进行免疫组织化学和超结构检测”Am.J.Pathol.147。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saishoji,T.: "Advanced glycation end products stimulate plasminogen activator activity via GM-CSF in RAW264.7 cells" Biochem.Biophys.Res.Commun.217. 278-285 (1995)
Saishoji,T.:“高级糖基化终末产物通过 RAW264.7 细胞中的 GM-CSF 刺激纤溶酶原激活剂活性”Biochem.Biophys.Res.Commun.217。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hammes,H-P.: "Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina" Lab.Invest.75. 325-338 (1996)
Hammes,H-P.:“通过高级糖基化对玻连蛋白进行修饰可改变体外和糖尿病视网膜的功能特性”Lab.Invest.75。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 43 条
Roles of CD36 and SR-BI as novel AGE-receptors
-
批准号:13470228
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.28万
-
财政年份:2001
-
负责人:HORIUCHI Seikoh
-
依托单位:
AGE Structures and their Biomedical Significance
-
批准号:10044305
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$8.38万
-
财政年份:1999
-
负责人:HORIUCHI Seikoh
-
依托单位:
Role of AGE Receptors in Diabetic Complications
-
批准号:11557081
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.64万
-
财政年份:1999
-
负责人:HORIUCHI Seikoh
-
依托单位:
Biological clearance system for advanced glycation end products (AGE) -Insulin signal regulates endocytic uptake of AGE-proteins
-
批准号:09470225
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:HORIUCHI Seikoh
-
依托单位:
Molecular Biology of Acyl-coenzyme A : cholesterol Acyltransferase
-
批准号:08044304
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.46万
-
财政年份:1996
-
负责人:HORIUCHI Seikoh
-
依托单位:
Structure and Function of Receptors for Advanced Glycation End Products of the Maillard Reaction
-
批准号:06454170
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.61万
-
财政年份:1994
-
负责人:HORIUCHI Seikoh
-
依托单位:
Non-enzymatic glycosylation of proteins in biological sytem and its physiological significance in aging process.
-
批准号:62570136
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1987
-
负责人:HORIUCHI Seikoh
-
依托单位: